Literature DB >> 29706652

LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.

Jing Zhao1,2, Peizhun Du1, Peng Cui3, Yunyun Qin1, Cheng'en Hu1, Jing Wu3, Zhongwen Zhou4, Wenhong Zhang5, Lunxiu Qin6,7, Guangjian Huang8.   

Abstract

Angiogenesis can aggravate gastric cancer progression. LncRNAs exert important roles in regulating various cancer behaviors. However, the functions and mechanisms of lncRNAs in angiogenesis remain largely unknown. Here we demonstrated that lncRNA PVT1 was upregulated and significantly associated with high-microvessel density and poor prognosis in gastric cancer. Through gain- and loss-of PVT1 expression, we found PVT1 could obviously induce angiogenesis within tumors, in addition to promoting tumor growth in vitro and in vivo. Mechanistically, PVT1 directly interacted with the signal transducer activator phospho-STAT3 in the nucleus, and increased its protein stability by protecting it from poly-ubiquitination and proteasome-dependent degradation. The binding of PVT1 activated the STAT3 signalling pathway, and successively elevated VEGFA expression to stimulate angiogenesis. The positive correlation of PVT1 and VEGFA expression was also verified in gastric cancer specimens, and high levels of PVT1 and VEGFA in combination frequently predicted shorter survival time. Moreover, we revealed that PVT1 was a STAT3-responsive lncRNA, as STAT3 could occupy the PVT1 promoter to facilitate its transcription. The positive feed-back loop of PVT1 and STAT3 continuously enhanced the oncogenic effects. Collectively, our study first elucidates the mechanism of PVT1-mediated angiogenesis via evoking the STAT3/VEGFA signalling axis, which provides promising target for developing new therapeutic strategy in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29706652     DOI: 10.1038/s41388-018-0250-z

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

Review 1.  Monoclonal antibody therapy of cancer.

Authors:  Gregory P Adams; Louis M Weiner
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

2.  Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.

Authors:  C L Yuan; H Li; L Zhu; Z Liu; J Zhou; Y Shu
Journal:  Neoplasma       Date:  2016       Impact factor: 2.575

3.  Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma.

Authors:  Z Xu; F Yang; D Wei; B Liu; C Chen; Y Bao; Z Wu; D Wu; H Tan; J Li; J Wang; J Liu; S Sun; L Qu; L Wang
Journal:  Oncogene       Date:  2016-11-14       Impact factor: 9.867

4.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

5.  A Positive Feedback Loop of lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion.

Authors:  Mi-Die Xu; Yiqin Wang; Weiwei Weng; Ping Wei; Peng Qi; Qiongyan Zhang; Cong Tan; Shu-Juan Ni; Lei Dong; Yusi Yang; Wanrun Lin; Qinghua Xu; Dan Huang; Zhaohui Huang; Yuqing Ma; Wei Zhang; Weiqi Sheng; Xiang Du
Journal:  Clin Cancer Res       Date:  2016-10-18       Impact factor: 12.531

6.  Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.

Authors:  Xue Wang; Wen Sun; Weifeng Shen; Mingyang Xia; Cheng Chen; Daimin Xiang; Beifang Ning; Xiuliang Cui; Hengyu Li; Xiaofeng Li; Jin Ding; Hongyang Wang
Journal:  J Hepatol       Date:  2016-01-23       Impact factor: 25.083

Review 7.  PVT1: a rising star among oncogenic long noncoding RNAs.

Authors:  Teresa Colombo; Lorenzo Farina; Giuseppe Macino; Paola Paci
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

8.  Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.

Authors:  Rong Kong; Er-bao Zhang; Dan-dan Yin; Liang-hui You; Tong-peng Xu; Wen-ming Chen; Rui Xia; Li Wan; Ming Sun; Zhao-xia Wang; Wei De; Zhi-hong Zhang
Journal:  Mol Cancer       Date:  2015-04-12       Impact factor: 27.401

9.  LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.

Authors:  Zhen-Zhen Chen; Lan Huang; Ya-Hong Wu; Wen-Jie Zhai; Ping-Ping Zhu; Yan-Feng Gao
Journal:  Nat Commun       Date:  2016-08-24       Impact factor: 14.919

10.  Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer.

Authors:  Youyou Zhang; Qun He; Zhongyi Hu; Yi Feng; Lingling Fan; Zhaoqing Tang; Jiao Yuan; Weiwei Shan; Chunsheng Li; Xiaowen Hu; Janos L Tanyi; Yi Fan; Qihong Huang; Kathleen Montone; Chi V Dang; Lin Zhang
Journal:  Nat Struct Mol Biol       Date:  2016-04-25       Impact factor: 15.369

View more
  127 in total

1.  Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.

Authors:  Martin Pichler; Cristian Rodriguez-Aguayo; Su Youn Nam; Mihnea Paul Dragomir; Recep Bayraktar; Simone Anfossi; Erik Knutsen; Cristina Ivan; Enrique Fuentes-Mattei; Sang Kil Lee; Hui Ling; Tina Catela Ivkovic; Guoliang Huang; Li Huang; Yoshinaga Okugawa; Hiroyuki Katayama; Ayumu Taguchi; Emine Bayraktar; Rajat Bhattacharya; Paola Amero; William Ruixian He; Anh M Tran; Petra Vychytilova-Faltejskova; Christiane Klec; Diana L Bonilla; Xinna Zhang; Sanja Kapitanovic; Bozo Loncar; Roberta Gafà; Zhihui Wang; Vittorio Cristini; Samir M Hanash; Menashe Bar-Eli; Giovanni Lanza; Ondrej Slaby; Ajay Goel; Isidore Rigoutsos; Gabriel Lopez-Berestein; George Adrian Calin
Journal:  Gut       Date:  2020-01-27       Impact factor: 23.059

2.  LncRNA TUG1 promoted osteogenic differentiation through promoting bFGF ubiquitination.

Authors:  Yang Yu; Ying Chen; Yi-Jing Zheng; Qi-Hao Weng; Si-Pin Zhu; Dong-Sheng Zhou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-01-06       Impact factor: 2.416

3.  TPTEP1 suppresses high glucose-induced dysfunction in retinal vascular endothelial cells by interacting with STAT3 and targeting VEGFA.

Authors:  Xiaoping Sun; Yuebing Lu; Tao Lei
Journal:  Acta Diabetol       Date:  2021-02-12       Impact factor: 4.280

Review 4.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.

Authors:  Jing Zhao; Li Li; Zhong-Ying Han; Zheng-Xin Wang; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 5.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

6.  The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.

Authors:  Ke-Tao Jin; Ze-Bei Lu; Jie-Qing Lv; Jun-Gang Zhang
Journal:  RNA Biol       Date:  2020-03-15       Impact factor: 4.652

Review 7.  Long Noncoding RNAs in Gastrointestinal Cancer: Tumor Suppression Versus Tumor Promotion.

Authors:  Mina Khajehdehi; Mohammad Khalaj-Kondori; Tayyebeh Ghasemi; Babak Jahanghiri; Mehdi Damaghi
Journal:  Dig Dis Sci       Date:  2020-03-17       Impact factor: 3.199

Review 8.  The regulatory roles and potential prognosis implications of long non-coding RNAs in gastric cancer.

Authors:  Yue Wang; Fan Yang; Qing Yang
Journal:  Histol Histopathol       Date:  2019-12-03       Impact factor: 2.303

9.  DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.

Authors:  Yan Qian; Wei Song; Xu Wu; Guowei Hou; Haixiao Wang; Xiao Hang; Tianfang Xia
Journal:  Dig Dis Sci       Date:  2020-04-01       Impact factor: 3.199

10.  The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS.

Authors:  Valentina Fragliasso; Akanksha Verma; Gloria Manzotti; Annalisa Tameni; Rohan Bareja; Tayla B Heavican; Javeed Iqbal; Rui Wang; Danilo Fiore; Valentina Mularoni; Wing C Chan; Priscillia Lhoumaud; Jane Skok; Eleonora Zanetti; Francesco Merli; Alessia Ciarrocchi; Oliver Elemento; Giorgio Inghirami
Journal:  Leukemia       Date:  2020-03-02       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.